Skip to main content
C&R Research Inc. logo

C&R Research Inc. — Investor Relations & Filings

Ticker · 359090 ISIN · KR7359090008 KO Professional, scientific and technical activities
Filings indexed 163 across all filing types
Latest filing 2026-02-24 AGM Information
Country KR South Korea
Listing KO 359090

About C&R Research Inc.

https://www.cnrres.com/

C&R Research Inc. is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. The company's offerings span the entire product lifecycle, from early-phase development and clinical trial design to regulatory affairs, data management, statistical consulting, and trial management. C&R Research is actively transitioning into a 'Data CRO' by integrating artificial intelligence (AI), Real-World Data (RWD), and platform-based solutions to enhance the efficiency and quality of clinical trials. The organization supports global studies, including navigating regulatory submissions with international bodies such as the U.S. FDA, and has demonstrated expertise in complex therapeutic areas like oncology, advanced biologics, and innovative medical devices.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회 집중일 개최 사유 신고' (Report on the reason for holding a general meeting on a concentrated date). It explains why the company, C&R Research, is holding its annual general meeting on a date that coincides with the 'concentrated date' (a period where many companies hold meetings). This is a specific regulatory disclosure required by the KOSDAQ exchange for transparency regarding shareholder meeting scheduling. Since it does not fit into the specific categories of AGM materials, proxy statements, or voting results, it falls under the general regulatory filing category.
2026-02-24 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding a decision on cash dividends ('현금ㆍ현물배당 결정'). It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a dividend announcement.
2026-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (C&R Research) announcing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for public companies to report preliminary financial performance before the final audit report is finalized. Since it provides key financial highlights and performance metrics for the fiscal year, it falls under the 'Earnings Release' category.
2026-02-24 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to contract amounts, counterparties, and dates. Since this is a specific regulatory disclosure regarding a material business contract and does not fit into categories like financial reports, board changes, or shareholder meetings, it is classified as a general Regulatory Filing (RNS).
2026-02-20 Korean
[기재정정]단일판매ㆍ공급계약체결
M&A Activity Classification · 95% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to a previously disclosed contract amount. Since this is a specific regulatory disclosure regarding a material contract update and does not fit into the other specialized categories like M&A or Share Issues, it is classified as a Regulatory Filing (RNS).
2026-02-09 Korean
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding a decision to increase short-term borrowings (단기차입금증가결정). It details the amount, purpose (acquisition of equity and operating funds), and board approval date. This type of corporate disclosure regarding financing activities falls under the 'Capital/Financing Update' category.
2026-01-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.